Minimally Invasive Treatment Modalities

2015 ◽  
pp. 90-100
Author(s):  
Nasır Yılmaz
Keyword(s):  
Minimally Invasive ◽  
Minimally Invasive Treatment ◽  
Treatment Modalities ◽  
Invasive Treatment

scholarly journals The Novel and Minimally Invasive Treatment Modalities for Female Pelvic Floor Muscle Dysfunction; Beyond the Traditional

2018 ◽  
Vol 35 (5) ◽  
pp. 358-366
Author(s):  
Yiğit Akın ◽  
Matthew Young ◽  
Muhammad Elmussareh ◽  
Nickolaus Charalampogiannis ◽  
Ali Serdar Gözen
Keyword(s):  
Minimally Invasive ◽  
Pelvic Floor ◽  
Pelvic Floor Muscle ◽  
Minimally Invasive Treatment ◽  
Treatment Modalities ◽  
Muscle Dysfunction ◽  
The Novel ◽  
Invasive Treatment ◽  
Female Pelvic Floor

scholarly journals Decision Making in Patients With Metastatic Spine. The Role of Minimally Invasive Treatment Modalities

2019 ◽  
Vol 9 ◽  
Author(s):  
Alfredo Conti ◽  
Güliz Acker ◽  
Anne Kluge ◽  
Franziska Loebel ◽  
Anita Kreimeier ◽  
...  
Keyword(s):  
Decision Making ◽  
Minimally Invasive ◽  
Minimally Invasive Treatment ◽  
Treatment Modalities ◽  
Invasive Treatment

scholarly journals Treatment of hypertrophic scars and keloids using an intralesional 1470 nm bare-fibre diode laser: a novel efficient minimally-invasive technique

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Ke Li ◽  
Fabio Nicoli ◽  
Chunxiao Cui ◽  
Wen Jing Xi ◽  
Ahmed Al-Mousawi ◽  
...  
Keyword(s):  
Minimally Invasive ◽  
Diode Laser ◽  
Minimally Invasive Treatment ◽  
Treatment Modalities ◽  
Invasive Technique ◽  
Hypertrophic Scars ◽  
Invasive Treatment ◽  
Keloid Scars ◽  
Wide Range ◽  
Bare Fibre

AbstractHypertrophic and keloid scars result from abnormal wound healing and can have a variable response to a number of available treatment modalities. The evolution of laser treatments in recent years has shown a wide range of clinical applications including their use in the treatment of scars. We investigated the effectiveness of a 1470 nm diode laser using an intralesional optical fibre delivery device in the treatment of hypertrophic and keloid scars. We evaluated its safety and efficacy as a novel and minimally invasive treatment alternative for scar modulation and volume reduction. A prospective cohort study was performed involving 21 patients with hypertrophic scars (HS) (n = 9) and keloids (n = 12) resulting from various aetiology. Patients were treated with one to three treatment sessions. Comprehensive evaluations were performed using the Vancouver Scar Scale, Doppler ultrasound, Cutometer, Mexameter and PeriCam PSI. Scar thickness was reduced by an average of 0.308 ± 0.138 cm (p < 0.001). In particular the two subgroups showed a significant 27.7% and 28.2% reduction in scar thickness of HS and Keloids, respectively. Scar firmness showed a significant improvement of 1.2% (p < 0.05) for HS, though for keloids this was 0.4% (p = 0.26). Keloids had a significant reduction in pigmentation at 21.3%. Blood perfusion had a significant reduction of 29.6% in HS and 22.7% in Keloids. Overall VSS total score improvement of 42% in the HS and at 37.9% in the Keloid subgroup. No adverse events such as hypo/hyperpigmentation, skin infection, or recurrence were reported. This study shows that the intralesional 1470 nm bare-fibre diode laser significantly improved hypertrophic and keloid scars based on both subjective and objective analyses and supports this type of laser therapy as a safe and effective minimally-invasive treatment option.

scholarly journals Novel Agents for Prevention of Caries: A Review

2019 ◽  
Vol 2 (12) ◽  
pp. 304-306
Author(s):  
Mansimranjit Kaur Uppal
Keyword(s):  
Dental Caries ◽  
Minimally Invasive ◽  
Minimally Invasive Treatment ◽  
Novel Agents ◽  
Treatment Modalities ◽  
Invasive Treatment ◽  
Tooth Structure ◽  
Ethical Duty ◽  
Preventive Methods

Now a day’s treatment modalities regarding dental caries have been changed with aim at maximum conservation of tooth structure and it’s an ethical duty of a dentist to provide their patients with minimally invasive treatment. Remineralization therapy is preferred in cases, where there is a chance of gaining success by preventive methods. Many novel caries preventive materials are now available in the market which contains components that have the ability to initiate remineralization.

scholarly journals EAU, AUA and NICE Guidelines on Surgical and Minimally Invasive Treatment of Benign Prostate Hyperplasia: A Critical Appraisal of the Guidelines Using the AGREE-II Tool

2021 ◽  
pp. 1-10
Author(s):  
Dmitry Enikeev ◽  
Vincent Misrai ◽  
Enrique Rijo ◽  
Roman Sukhanov ◽  
Denis Chinenov ◽  
...  
Keyword(s):  
Minimally Invasive ◽  
Treatment Options ◽  
Stakeholder Involvement ◽  
Minimally Invasive Treatment ◽  
Invasive Treatment ◽  
Agree Ii ◽  
Prostate Hyperplasia ◽  
Assessment Score ◽  
Nice Guideline ◽  
Agree Ii Tool

<b><i>Objective:</i></b> To critically appraise the methodological rigour of the clinical practice guidelines (CPGs) vis-à-vis BPH surgery as used by specialist research associations in the US, Europe and UK, and to compare whether the guidelines cover all or only some of the available treatments. <b><i>Methods:</i></b> The current guidelines issued by the EUA, AUA and NICE associations have been analyzed by 4 appraisers using the AGREE-II instrument. We also compared the recommendations given in the guidelines for surgical and minimally invasive treatment to find out which of these CPGs include most of the available treatment options. <b><i>Results:</i></b> According to the AGREE II tool, the median scores of domains were: domain 1 scope and purpose 66.7%, domain 2 stakeholder involvement 50.0%, domain 3 rigor of development 65.1%, domain 4 clarity of presentation 80.6%, domain 5 applicability 33.3%, domain 6 editorial independence 72.9%. The overall assessment according to AGREE II is 83.3%. The NICE guideline scored highest on 5 out of 6 domains and the highest overall assessment score (91.6%). The EAU guideline scored lowest on 4 out of 6 domains and has the lowest overall assessment score (79.1%). <b><i>Conclusions:</i></b> The analyzed CPGs comprehensively highlight the minimally invasive and surgical treatment options for BPH. According to the AGREE II tool, the domains for clarity of presentation and editorial independence received the highest scores. The stakeholder involvement and applicability domains were ranked as the lowest. Improving the CPG in these domains may help to improve the clinical utility and applicability of CPGs.

Sign in / Sign up

Export Citation Format

Share Document